Skip to main content

Table 3 Association of NSAID use with COVID-19 outcomes as measured by logistic regression. AKI: acute kidney injury; ECMO: extracorporeal membrane oxygenation

From: NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study

  OR (95% CI) p value
COVID severity (severe or dead) 0.57 (0.53–0.61) < 0.0001
Mortality/hospice 0.51 (0.47–0.56) < 0.0001
Invasive ventilation 0.59 (0.55–0.64) < 0.0001
AKI 0.67 (0.63–0.72) < 0.0001
ECMO 0.51 (0.36–0.7) < 0.0001